Product image of Haloperidol Richter (Haloperidol) supplied by GNH India

Haloperidol Richter

Active Ingredient:
Haloperidol
Origin:
EU

Haloperidol Richter (Haloperidol)

Haloperidol Richter is an injectable solution containing the antipsychotic agent haloperidol. The product is supplied in a standard concentration for intramuscular administration and is marketed in the European Union as a prescription‑only medication. As a butyrophenone derivative, it acts as a dopamine D2 receptor antagonist and is used under medical supervision for specific psychiatric conditions. It is intended for use by qualified health professionals in acute care settings.

Manufacturer / TM Owner

Gedeon Richter România S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Haloperidol Richter is indicated for the management of several acute psychiatric conditions where rapid control of symptoms is required.

  • Schizophrenia, particularly acute exacerbations
  • Acute psychotic episodes associated with mood disorders
  • Manic episodes in bipolar disorder when immediate calming is needed
  • Severe agitation or aggression that poses a risk to the patient or others

Side Effects

Side effects of haloperidol injectable solution vary in frequency and severity; they are categorized as common or serious.

Common

  • Drowsiness or sedation
  • Extrapyramidal symptoms (e.g., tremor, rigidity)
  • Dry mouth
  • Orthostatic hypotension

Serious

  • Neuroleptic malignant syndrome
  • Tardive dyskinesia
  • Severe cardiac arrhythmias
  • Hyperprolactinemia with galactorrhea

Precautions & Warnings

When prescribing Haloperidol Richter, clinicians should consider several precautionary measures to minimize risk.

  • Assess cardiovascular status before initiating therapy.
  • Monitor for signs of extrapyramidal reactions, especially in the first few days.
  • Use the lowest effective dose for the shortest duration needed.
  • Evaluate liver and renal function in patients with organ impairment.
  • Exercise caution in patients with a history of seizures or neuroleptic malignant syndrome.

Avoid Interactions

Haloperidol injectable solution can interact with other medications; some combinations should be avoided while others require careful monitoring.

Avoid

  • Other dopamine antagonists or high‑potency antipsychotics
  • Drugs that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics)
  • CNS depressants such as benzodiazepines in high doses

Use with caution

  • Anticholinergic agents (may mask extrapyramidal symptoms)
  • CYP3A4 inhibitors or inducers affecting haloperidol metabolism
  • Lithium therapy (increased risk of neurotoxicity)

Frequently Asked Questions

Haloperidol Richter is administered by intramuscular injection as an injectable solution.

It is used for acute schizophrenia, acute psychosis, manic episodes in bipolar disorder, and severe agitation requiring rapid symptom control.

Haloperidol acts as a dopamine D2 receptor antagonist, reducing dopaminergic neurotransmission that contributes to psychotic symptoms.

Common side effects include drowsiness, extrapyramidal symptoms such as tremor or rigidity, dry mouth, and orthostatic hypotension.

Serious reactions can include neuroleptic malignant syndrome, tardive dyskinesia, severe cardiac arrhythmias, and hyperprolactinemia with galactorrhea.

Caution is advised because haloperidol can prolong the QT interval; patients with known cardiac arrhythmias should be closely monitored.

Combining haloperidol with other dopamine antagonists or high‑potency antipsychotics is generally avoided due to increased risk of adverse effects.

Clinicians should evaluate hepatic and renal function and may need to adjust the dose or duration in patients with significant organ impairment.

Monitoring should focus on cardiovascular status, extrapyramidal symptoms, and any signs of neuroleptic malignant syndrome.

The pregnancy safety category for haloperidol injectable solution is listed as unknown; it should only be used if the potential benefit justifies the potential risk.

The product should be kept in its original container, protected from light, and stored at controlled room temperature as specified by the manufacturer.

If severe hypotension occurs, the patient should be placed in a supine position, vital signs monitored, and medical assistance provided promptly.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Haloperidol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT